Fujitsu Embarks on Joint Research with National Cancer Center Japan to Create New Services for Drug Development and Clinical Trials
TOKYO, Mar 18, 2021 - (JCN Newswire) - Fujitsu today announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japan.
- TOKYO, Mar 18, 2021 - (JCN Newswire) - Fujitsu today announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japan.
- In collaboration with the National Cancer Center, Fujitsu is implementing three projects to utilize real-world data at the National Cancer Center Hospital East.
- - Fujitsu will promote efforts to adapt clinical trial data in Japan to global standards and support active participation in international clinical trials.
- Through the provision of these platforms and services to pharmaceutical companies, Fujitsu aims to contribute to the streamlining of drug development and clinical trials.